NUVECTRA ALGOVITA SPINAL CORD STIMULATION; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED (PAIN RELIEF)
|
Back to Search Results |
|
Model Number 1084-60T |
Device Problem
Detachment Of Device Component (1104)
|
Patient Problem
Device Embedded In Tissue or Plaque (3165)
|
Event Date 06/30/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).
|
|
Event Description
|
Patient underwent a bilateral spinal cord stimulation trial procedure utilizing the algovita spinal cord stimulation (scs) trial system with two percutanous 1084-60t, 8-electrode leads, (b)(6) 2016.The patient successfully completed the trial with excellent pain relief and the leads were extracted, (b)(6) 2016.The first lead was removed routinely.The health care professional reported resistance during extraction of the second percutaneous lead.Once the lead was free of the patient, it was determined that the distal electrode portion of the percutaneous lead remained in the patient.The patient was placed on an antibiotic regimen and bandage was placed over the implant site.Because the trial procedure was deemed successful, the patient was scheduled for a permanent scs implant.The patient underwent the procedure for a permanent scs system implant on (b)(6) 2016.During the procedure, the percutaneous lead fragment was easily removed from the epidural space without incident, and a surgical / paddle lead was successfully placed.There were no additional surgical or patient complications noted and the patient's post-operative status has been reported as fine.
|
|
Manufacturer Narrative
|
(b)(4).Manufacture reference number is (b)(4).Corrections: common device name: changed from "stimulator, spinal-cord, implanted (pain relief)" to "stimulator, spinal-cord, totally implanted (pain relief)".Product code: changed from "gzb" to "lgw".
|
|
Event Description
|
Patient underwent a bilateral spinal cord stimulation trial procedure utilizing the algovita spinal cord stimulation (scs) trial system with two percutanous1084-60t, 8-electrode leads, (b)(6) 2016.The patient successfully completed the trial with excellent pain relief and the leads were extracted, (b)(6) 2016.The first lead was removed routinely.The health care professional reported resistance during extraction of the second percutaneous lead.Once the lead was free of the patient, it was determined that the distal electrode portion of the percutaneous lead remained in the patient.The patient was placed on an antibiotic regimen and bandage was placed over the implant site.Because the trial procedure was deemed successful, the patient was scheduled for a permanent scs implant.The patient underwent the procedure for a permanent scs system implant on (b)(6) 2016.During the procedure, the percutaneous lead fragment was easily removed from the epidural space without incident, and a surgical / paddle lead was successfully placed.There were no additional surgical or patient complications noted and the patient's post-operative status has been reported as fine.
|
|
Search Alerts/Recalls
|
|
|